Abstract
MicroRNAs-21 (miRNAs-21), which promote tumor development and invasion by facilitating tumor cell proliferation and inhibiting apoptosis, is identified as a reliable biomarker for early cancer detection and prognosis. Herein, a CRISPR/Cas13a-mediated dual-modal biosensing platform was designed based on the Zn0.5Cd0.5S/Ti3C2 (ZCS/TC) Schottky heterojunction and implemented for monitoring miRNAs-21. Specifically, two-dimensional TC nanosheets with a large surface-to-volume ratio produced ample growth sites for the ZCS nanosphere. Moreover, the formation of Schottky heterojunctions at the ZCS/TC interface, validated by density functional theory calculations, can enhance their photoelectric conversion efficiency, providing a satisfactory initial signal for the subsequent implementation of a photoelectrochemical (PEC) biosensor. Furthermore, with the assistance of the MnO2-mediated CRISPR-Cas13a strategy, the dual-mode detection of miRNAs-21 was initiated via visualization and the use of the PEC biosensor. Under the optimized conditions, the linear range of the biosensor for detecting miRNAs-21 was 0.5 fM-1.0 nM and the detection limit was 0.21 fM. The developed platform can be used for the early detection and monitoring of various diseases, specifically cancer, and help create more research opportunities in this field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.